Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2011 1
2017 3
2019 2
2020 2
2021 2
2022 1
2023 4
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment.
de Rouw N, Otten LS, Kicken MP, Piet B, Biesma B, van Veggel B, Steendam CMJ, van den Borne B, Hendriks LEL, Croes S, Dingemans AC, Dumoulin DW, Mathijssen RHJ, Burgers JA, Huitema ADR, Derijks HJ, Deenen MJ, van den Heuvel MM, Ter Heine R. de Rouw N, et al. Among authors: steendam cmj. Clin Pharmacol Ther. 2025 Sep;118(3):715-722. doi: 10.1002/cpt.3735. Epub 2025 May 27. Clin Pharmacol Ther. 2025. PMID: 40421804 Free PMC article.
Pulmonary artery aneurysms and thrombi.
Steendam CMJ, Diederik AL, Dendooven A, Snijder RJ, Herder GJ. Steendam CMJ, et al. Thorax. 2017 Dec;72(12):1167-1168. doi: 10.1136/thoraxjnl-2016-209752. Epub 2017 Feb 7. Thorax. 2017. PMID: 28174341 No abstract available.
Connecting the dots: (RANKL+) extracellular vesicle count in blood plasma in relation to bone metastases, skeletal related events and osimertinib treatment in patients with EGFR mutated non-small cell lung cancer.
Brouns AJWM, Robbesom-van den Berge IJ, Ernst SM, Steendam CMJ, Woud WW, Wu L, Dingemans AC, Hendriks LEL, van Driel M. Brouns AJWM, et al. Among authors: steendam cmj. Transl Lung Cancer Res. 2025 Mar 31;14(3):761-774. doi: 10.21037/tlcr-24-1007. Epub 2025 Mar 19. Transl Lung Cancer Res. 2025. PMID: 40248741 Free PMC article.
Improving the tolerability of osimertinib by identifying its toxic limit.
Agema BC, Veerman GDM, Steendam CMJ, Lanser DAC, Preijers T, van der Leest C, Koch BCP, Dingemans AC, Mathijssen RHJ, Koolen SLW. Agema BC, et al. Among authors: steendam cmj. Ther Adv Med Oncol. 2022 Jun 3;14:17588359221103212. doi: 10.1177/17588359221103212. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35677320 Free PMC article.
Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC.
Gulikers JL, Veerman GDM, Jebbink M, Kruithof PD, Steendam CMJ, Boosman RJ, Mathijssen RHJ, Tjan-Heijnen VCG, Driessen JHM, Dursun S, Smit EF, Dingemans AC, van Geel RMJM, Croes S, Hendriks LEL. Gulikers JL, et al. Among authors: steendam cmj. JTO Clin Res Rep. 2024 Feb 20;5(4):100656. doi: 10.1016/j.jtocrr.2024.100656. eCollection 2024 Apr. JTO Clin Res Rep. 2024. PMID: 38550297 Free PMC article.
Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer.
Steendam CMJ, Veerman GDM, Pruis MA, Atmodimedjo P, Paats MS, van der Leest C, von der Thüsen JH, Yick DCY, Oomen-de Hoop E, Koolen SLW, Dinjens WNM, van Schaik RHN, Mathijssen RHJ, Aerts JGJV, Dubbink HJ, Dingemans AC. Steendam CMJ, et al. Cancers (Basel). 2020 Oct 29;12(11):3179. doi: 10.3390/cancers12113179. Cancers (Basel). 2020. PMID: 33138052 Free PMC article.
24 results